154 related articles for article (PubMed ID: 19951182)
1. Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.
Tosh PK; Kennedy RB; Vierkant RA; Jacobson RM; Poland GA
Viral Immunol; 2009 Dec; 22(6):451-6. PubMed ID: 19951182
[TBL] [Abstract][Full Text] [Related]
2. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.
Lambert ND; Haralambieva IH; Ovsyannikova IG; Larrabee BR; Pankratz VS; Poland GA
Immunol Res; 2014 Jan; 58(1):1-8. PubMed ID: 24375276
[TBL] [Abstract][Full Text] [Related]
3. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.
Dhiman N; Ovsyannikova IG; Ryan JE; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Clin Exp Immunol; 2005 Dec; 142(3):498-504. PubMed ID: 16297162
[TBL] [Abstract][Full Text] [Related]
4. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
[TBL] [Abstract][Full Text] [Related]
5. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
6. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age.
Haralambieva IH; Eberhard KG; Ovsyannikova IG; Grill DE; Schaid DJ; Kennedy RB; Poland GA
Eur J Immunol; 2021 Jul; 51(7):1824-1838. PubMed ID: 33818775
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.
Kennedy RB; Ovsyannikova IG; Haralambieva IH; Lambert ND; Pankratz VS; Poland GA
Immunogenetics; 2014 Aug; 66(7-8):493-9. PubMed ID: 24811271
[TBL] [Abstract][Full Text] [Related]
9. Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
Crooke SN; Ovsyannikova IG; Kennedy RB; Warner ND; Poland GA
Vaccine; 2020 Nov; 38(50):7897-7904. PubMed ID: 33158591
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
Voigt EA; Haralambieva IH; Larrabee BL; Kennedy RB; Ovsyannikova IG; Schaid DJ; Poland GA
J Infect Dis; 2018 Jan; 217(4):560-566. PubMed ID: 29253144
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees.
Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H
Vaccine; 1999 Apr; 17(15-16):2051-8. PubMed ID: 10217606
[TBL] [Abstract][Full Text] [Related]
12. How to determine protective immunity in the post-vaccine era.
Charlton CL; Lai FY; Dover DC
Hum Vaccin Immunother; 2016 Apr; 12(4):903-6. PubMed ID: 26811063
[TBL] [Abstract][Full Text] [Related]
13. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
Carryn S; Feyssaguet M; Povey M; Di Paolo E
Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
[TBL] [Abstract][Full Text] [Related]
14. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
Kontio M; Jokinen S; Paunio M; Peltola H; Davidkin I
J Infect Dis; 2012 Nov; 206(10):1542-8. PubMed ID: 22966129
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
J Infect Dis; 2005 Feb; 191(4):515-9. PubMed ID: 15655774
[TBL] [Abstract][Full Text] [Related]
16. Faster waning of the rubella-specific immune response in young pregnant women immunized with MMR at 15 months.
Kung WJ; Shih CT; Shih YL; Liu LY; Wang CH; Cheng YW; Liu HC; Lin CC
Am J Reprod Immunol; 2020 Oct; 84(4):e13294. PubMed ID: 32569402
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
Jokinen S; Osterlund P; Julkunen I; Davidkin I
J Infect Dis; 2007 Sep; 196(6):861-7. PubMed ID: 17703416
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
Immunogenetics; 2015 Oct; 67(10):547-61. PubMed ID: 26329766
[TBL] [Abstract][Full Text] [Related]
19. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
McLean HQ; Fiebelkorn AP; Ogee-Nwankwo A; Hao L; Coleman LA; Adebayo A; Icenogle JP
Vaccine; 2018 Sep; 36(38):5732-5737. PubMed ID: 30107992
[TBL] [Abstract][Full Text] [Related]
20. A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays.
Greenwood NP; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
Viral Immunol; 2010 Aug; 23(4):353-7. PubMed ID: 20712479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
